tiprankstipranks
Soleno Therapeutics Corrects Q4 Financial Reporting Error
PremiumCompany AnnouncementsSoleno Therapeutics Corrects Q4 Financial Reporting Error
2M ago
Soleno Therapeutics reports Q4 EPS (33c), consensus (27c)
PremiumThe Fly
Soleno Therapeutics reports Q4 EPS (33c), consensus (27c)
2M ago
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
PremiumPress Releases
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
2M ago
Soleno Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe FlySoleno Therapeutics initiated with an Overweight at Piper Sandler
3M ago
Soleno Therapeutics Expands Equity Incentive Plan
PremiumCompany Announcements
Soleno Therapeutics Expands Equity Incentive Plan
3M ago
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesSoleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4M ago
Soleno Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Soleno Therapeutics files automatic mixed securities shelf
4M ago
Soleno Therapeutics price target raised to $47 from $44 at Oppenheimer
PremiumThe Fly
Soleno Therapeutics price target raised to $47 from $44 at Oppenheimer
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100